E-LIB Suche - Ergebnisse für: Sendeyo, Kelhia

1

CMIP is a negative regulator of T cell signaling:

Oniszczuk, Julie ; Sendeyo, Kelhia ; Chhuon, Cerina...
Cellular & Molecular Immunology. 17 (2019) 10 - p. 1026-1041 , 2019

Link: https://doi.org/10.1038/..

2

A novel combination of chemotherapy and immunotherapy contr..:

Burlion, Aude ; Ramos, Rodrigo N. ; KC, Pukar...
OncoImmunology. 8 (2019) 7 - p. e1596005 , 2019

Link: https://doi.org/10.1080/..

3

Expression of CMIP in podocytes is restricted to specific c..:

Bouachi, Khedidja ; Moktefi, Anissa ; Zhang, Shao-yu...
PLOS ONE. 13 (2018) 11 - p. e0207066 , 2018

Link: https://doi.org/10.1371/..

4

NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab..:

Boumediene, Ahmed ; Vachin, Pauline ; Sendeyo, Kelhia...
Journal of Autoimmunity. 88 (2018) - p. 91-102 , 2018

Link: https://doi.org/10.1016/..

5

SO026FSGS POST-TRANSPLANT RECURRENCE: IDENTIFICATION OF A P..:

Ollero, Mario ; Hénique, Carole ; Chhuon, Cerina...
Nephrology Dialysis Transplantation. 31 (2016) suppl_1 - p. i82-i82 , 2016

Link: https://doi.org/10.1093/..

6

Inhibition of the JAK/STAT Signaling Pathway in Regulatory ..:

Goldstein, Jérémie D. ; Burlion, Aude ; Zaragoza, Bruno...
PLOS ONE. 11 (2016) 4 - p. e0153682 , 2016

Link: https://doi.org/10.1371/..

7

Immunopathogenesis of idiopathic nephrotic syndrome with re..:

Sahali, Djillali ; Sendeyo, Kelhia ; Mangier, Melanie...
Seminars in Immunopathology. 36 (2014) 4 - p. 421-429 , 2014

Link: https://doi.org/10.1007/..

8

CMIP is a negative regulator of T cell signaling:

Oniszczuk, Julie ; Sendeyo, Kelhia ; Chhuon, Cerina...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41423-019-0266-5. , 2020

Link: https://hal.u-pec.fr/hal..

9

CMIP is a negative regulator of T cell signaling:

Oniszczuk, Julie ; Sendeyo, Kelhia ; Chhuon, Cerina...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41423-019-0266-5. , 2020

Link: https://hal.u-pec.fr//ha..

10

A novel combination of chemotherapy and immunotherapy contr..:

Burlion, Aude ; Ramos, Rodrigo ; Kc, Pukar...
info:eu-repo/semantics/altIdentifier/doi/10.1080/2162402X.2019.1596005. , 2019

Link: https://hal.sorbonne-uni..

11

A novel combination of chemotherapy and immunotherapy contr..:

Burlion, Aude ; Ramos, Rodrigo ; Kc, Pukar...
info:eu-repo/semantics/altIdentifier/doi/10.1080/2162402X.2019.1596005. , 2019

Link: https://hal.sorbonne-uni..

12

A novel combination of chemotherapy and immunotherapy contr..:

Burlion, Aude ; Ramos, Rodrigo ; KC, Pukar...
info:eu-repo/semantics/altIdentifier/doi/10.1080/2162402X.2019.1596005. , 2019

Link: https://hal.sorbonne-uni..

13

A novel combination of chemotherapy and immunotherapy contr..:

Burlion, Aude ; Ramos, Rodrigo ; Kc, Pukar...
info:eu-repo/semantics/altIdentifier/doi/10.1080/2162402X.2019.1596005. , 2019

Link: https://hal.sorbonne-uni..

14

A novel combination of chemotherapy and immunotherapy contr..:

Burlion, Aude ; Ramos, Rodrigo N ; KC, Pukar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527285/. , 2019

Link: http://www.ncbi.nlm.nih...

15

A novel combination of chemotherapy and immunotherapy contr..:

Burlion, Aude ; Ramos, Rodrigo ; Kc, Pukar...
info:eu-repo/semantics/altIdentifier/doi/10.1080/2162402X.2019.1596005. , 2019

Link: https://hal.sorbonne-uni..